- Home
- IPSC vs CATO Comparison
IPSC vs CATO Comparison
Compare IPSC & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- CATO
- Stock Information
- Founded
- IPSC 2019
- CATO 1946
- Country
- IPSC United States
- CATO United States
- Employees
- IPSC N/A
- CATO N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- CATO Clothing/Shoe/Accessory Stores
- Sector
- IPSC Health Care
- CATO Consumer Discretionary
- Exchange
- IPSC Nasdaq
- CATO Nasdaq
- Market Cap
- IPSC 58.1M
- CATO 63.9M
- IPO Year
- IPSC 2021
- CATO N/A
- Fundamental
- Price
- IPSC $0.48
- CATO $3.31
- Analyst Decision
- IPSC Strong Buy
- CATO
- Analyst Count
- IPSC 5
- CATO 0
- Target Price
- IPSC $4.67
- CATO N/A
- AVG Volume (30 Days)
- IPSC 480.0K
- CATO 105.6K
- Earning Date
- IPSC 03-19-2025
- CATO 03-20-2025
- Dividend Yield
- IPSC N/A
- CATO 10.46%
- EPS Growth
- IPSC N/A
- CATO N/A
- EPS
- IPSC N/A
- CATO N/A
- Revenue
- IPSC $6,589,000.00
- CATO $649,806,000.00
- Revenue This Year
- IPSC N/A
- CATO N/A
- Revenue Next Year
- IPSC N/A
- CATO N/A
- P/E Ratio
- IPSC N/A
- CATO N/A
- Revenue Growth
- IPSC 194.81
- CATO N/A
- 52 Week Low
- IPSC $0.47
- CATO $2.64
- 52 Week High
- IPSC $4.43
- CATO $6.70
- Technical
- Relative Strength Index (RSI)
- IPSC 26.49
- CATO 50.77
- Support Level
- IPSC $0.54
- CATO $2.87
- Resistance Level
- IPSC $0.59
- CATO $4.00
- Average True Range (ATR)
- IPSC 0.05
- CATO 0.39
- MACD
- IPSC -0.00
- CATO 0.08
- Stochastic Oscillator
- IPSC 3.08
- CATO 42.02
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories primarily in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.